Propranolol treatment in periocular pediatric patients with hemangiomas

Insight - Journal of the American Society of Ophthalmic Registered Nurses

Volumn 35, Issue 1, 2010, Pages 22-23

  Boyce, Jennifer ^a   Dodge Palomba, Sylvia ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPRANOLOL;

ARTICLE; DOSE RESPONSE; EYELID TUMOR; FEMALE; HEMANGIOMA; HUMAN; INFANT; MALE; NEWBORN; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EYELID NEOPLASMS; FEMALE; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROPRANOLOL; TREATMENT OUTCOME;

EID: 75449116580     PISSN: 1060135X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Nyguyen J, Fay A. Pharmacologic Therapy for Periocular Infantile Hemangiomas. Seminiars in Ophthalmology. 2009 May-June: 24(3): 178-184.
2. Schlossen K, MPAS, PA.C. Infantile Hemangioma: How to treat this benign neoplasm of childhood. JAAPA Journal of the American Academy of Physician Assistants. May 5, 2009.
3. Wolters Kluwer Health/Lipincott Williams & Wilkins. Nursing2008 Drug Handbook, 28th Edition: 276-278.